Micro-hematology Analyzer for Viral/Bacterial Description
Status unconfirmed
Conditions studied: Infection Viral, Infection, Bacterial
In brief
The purpose of the study is to evaluate the reliability and accuracy of a newly developed point-of-care analyzer, theCytoTracker, to measure complete blood count (CBC) parameters and discriminate between viral and bacterial infections.
Key facts
- Study ID
- NCT05090319
- Run by
- RizLab Health, Inc.
- People needed
- 200
- Starts
- 2021-07-25
- Expected to finish
- 2022-07-24
- Last updated by the study team
- 2021-11-03
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- COVID positive or suspected/confirmed bacterial infection (lower UTI, pneumonia, septecemia, etc). -Adults 18 years of age and older. -Meet SIRS criteria anytime during the ED presentation.
You may not qualify if…
- Subjects who are unable to give informed consent will be excluded
- Subjects with the following conditions will also be excluded: Known white blood cell, neutrophil, and lymphocyte disorders Active cancer patients; For solid tumors, subject will be excluded if he/she has received chemotherapy in the last 3 months.
- Subjects who are pregnant
Where it is running
- Ben Taub Hospital — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.